second-line - Globe Thesis

Keyword [second-line] Result: 61 - 80 \| Page: 4 of 7
61.	Clinical Study Of Irinotecan Or Docetaxel In Second-line Treatment Of Advanced Esophageal Cancer
62.	Outcome Of Molecular Targeted Agents Plus Chemotherapy For Second-line Therapy Of Metastatic Colorectal Cancer: A Meta-analysis Of Randomized Trials
63.	The Effect Of Saccharomyces Boulardii (S.boulardii) In Helicobacter Pylori Rescue Therapy
64.	Efficacy And Safety Of Thalidomide Combined With IRIS In The Treatment Of Advanced Gastric Cancer
65.	The Retrospective Analysis Of Combination Chemotherapy Compared With Single-agent Chemotherapy As Second-line Treatment In Advanced Non-small-cell Lung Cancer
66.	The Efficacy And Prognostic Factors Of Cetuximab Combined With Nedaplatin And 5-fluorouracil As Second-line Treatment For Advanced Esophageal Squamous Cell Carcinoma
67.	Retrospective Analysis Of Oxaliplatin Combined With S-1(SOX) As Second-line Treatment For Advanced Gastric Cancer
68.	Analysis Of Survival And Prognosis In Patients With BCLC-C Hepatocellular Carcinoma After Sorafenib Failure
69.	Efficacy Of Caspofungin Combined With Trimethoprim/Sulfamethoxazole As First-line Therapy To Treat Non-HIV Patients With Severe Pneumocystis Pneumonia
70.	Comparison Of The Clinical Outcome Of Gefitinib For Advanced Lung Adenocarcinoma With Positive Epidermal Growth Factor Receptor Mutated In Exon 21 Or 19 Del Between Patients Treated With First And Second Line Therapy
71.	Analysis Of The Efficacy And Prognostic Factors Of Second Line Treatment Of Small Cell Lung Cancer
72.	AP Versus DP Chemotherapy Regimen As Second-line Therapy In EGFR-TKIs Treated Advanced Non-small-cell Lung Cancer Patients With EGFR Mutations
73.	Retrospective Clinical Study Of Nilotinib As A Second-line Therapy In Imatinib Treatment-failure Patients With Chronic Myeloid Leukemia In Chronic Phase
74.	Paclitaxel Or Irinotecan Monotherapy Or Combined With S-1 Second-line Treatment Of Advanced Gastric Cancer Clinical Study
75.	The Efficacy And Safety Of Apatinib In Advanced Non-small Cell Lung Cancer After Second-line And More Regimens Failure
76.	Efficacy And Safety Of Target Drug As Second Line Treatment For Advanced Gastric Cancer : A Meta Analysis
77.	A Retrospective Study Of The Efficacy And Toxicity Of IP Versus CAO As Salvage Treatment In Refractory Or Recurrent Small Cell Lung Cancer
78.	Progress In Second-line Chemotherapy For Advanced Gastric Cancer
79.	Efficacy And Treatment-related Toxicities Associated With PD-1/PD-L1 Inhibitors In Previously-treated Advanced Non-small Cell Lung Cancer(NSCLC):Systematic Review And Meta-analysis
80.	Detection Of Second-line Drugs Resistance Mutations In Mycobacterium Tuberculosis By Multicolor Melting Curve Analysis
<<First <Prev Next> Last>> Jump to